人民财讯12月5日电，企查查APP显示，近日，成都太保鑫健一期股权投资基金合伙企业(有限合伙)成 立，出资额约50亿元，经营范围包括以私募基金从事股权投资、投资管理、资产管理等活动。企查查股 权穿透显示，该企业由中国太保（601601）旗下中国太平洋人寿保险股份有限公司、太保私募基金管理 有限公司共同出资。 ...

Core Viewpoint - The insurance industry in China is facing both opportunities and challenges due to the prolonged low interest rate environment, which poses risks related to interest rate spreads and necessitates improved asset-liability management strategies [2][3]. Group 1: Challenges and Regulatory Environment - One of the main challenges for the insurance industry is the continuous decline in interest rates, which affects the pricing of insurance products and the cost of liabilities, leading to potential risks in interest rate spreads [2][3]. - The "New National Ten Articles" issued by the State Council emphasizes the need for enhanced asset-liability linkage regulation and the establishment of mechanisms for interest rate transmission and liability cost adjustment [2]. Group 2: Asset-Liability Management Strategies - The characteristics of insurance funds require long-term matching, as approximately 90% of insurance assets are derived from policy liabilities, necessitating a focus on long-term asset management [3]. - The core of asset-liability management is to allocate long-term funds to assets that can withstand shocks from interest rates, credit, and liquidity, ensuring financial goals and regulatory compliance are met [3][4]. - Traditional asset allocation strategies are no longer viable; the industry must explore new asset-liability management and allocation strategies to find long-term logic that can endure economic cycles [3][4]. Group 3: Principles and Optimization of Asset Allocation - Insurance asset-liability management should adhere to three principles: safety, profitability, and liquidity, to achieve cost-revenue matching, term structure matching, and cash flow matching [4]. - Continuous optimization of asset allocation is essential, with a focus on long-term interest rate bonds in fixed income, a core strategy of dividend value in equity, and active investment in alternative assets such as equity, mezzanine, and REITs [5]. Group 4: Cost Management and Technological Integration - On the liability side, efforts should be made to reduce costs, optimize structures, and increase flexibility, including lowering new policy interest rates and adopting designs that encourage clients to accept yield fluctuations [5]. - The company aims to enhance its resilience to economic cycles through precise risk control and operational efficiency using technology [5]. Group 5: Investment Philosophy and Internationalization - The investment philosophy of the company is centered on value, long-term, and responsible investing, with a "barbell" allocation structure balancing fixed income, public equity, and alternative assets [5]. - The company is also exploring new investment areas, including active allocation in gold assets based on long-term logic and gradually advancing internationalization with Hong Kong as a hub [5].

苏罡指出，保险资金的属性决定了长期匹配刚需。保险资产的特点是约90%源自保单负债，负债期限 长，对资金端的长期化管理提出了天然要求。负债端有现金流刚性、成本黏性高等特点，若资产端收益 长期下行，将侵蚀资本、加大偿付能力波动。因此，资产负债管理的核心是将长期资金配置到能穿越利 率、信用、流动性冲击的资产，锁定安全垫，确保财务目标、客户保障与监管底线不失守。 "传统的配置策略必须改变。"苏罡表示，过去优质信用类资产比较多的时候，可以通过信用类资产形成 安全垫覆盖保障成本，再通过权益类资产或另类资产博取长期风险溢价，但现在这种模式已经行不通 了。在当前利率水平和权益市场估值水平之下，信用利差极致压缩、非标优质资产稀缺，保险资金再投 资承压，行业必须思考新的资产负债管理和资产配置策略，寻找穿越周期的长期逻辑。 苏罡称："保险资产负债管理应坚持三个原则，即坚持安全性、盈利性和流动性原则，来实现成本收益 匹配、期限结构匹配和现金流匹配，并从更丰富的维度以及压力测试角度，去看待匹配的适配度。"因 此，必须推进资产负债协同，建立"以产品为原点"的资产负债管理机制。资产端要在持续跟踪分析负债 特点的基础上制定大类资产配置方案， ...

Group 1 - The 2025 Shanghai Marathon was inaugurated at the Bund Jin Niu Square, with China Pacific Insurance (CPIC) serving as the official insurance sponsor for the fourth consecutive year [2] - CPIC provided comprehensive risk coverage with a total insurance amount of nearly 20 billion yuan, including personal accident insurance, public liability insurance, and accidental medical insurance for all participants and staff [2] - A dedicated claims team and a green claims channel were established, offering a bilingual service hotline and simplified paperless real-time compensation for claims under 10,000 yuan, enhancing the overall service experience [2] Group 2 - Changjiang Pension Insurance launched a creative mini-game called "Life Track Simulator" on WeChat, allowing users to input their age and income to generate a personalized retirement financial handbook [2] - The company designed a visual comparison of "Corporate Annuity Growth Curve" and "Marathon Champion Completion Time," illustrating the value of early accumulation and long-term savings in retirement financial planning [2] - CPIC and Changjiang Pension will continue to uphold their service philosophy of responsibility, wisdom, and warmth, supporting participants in their life marathons [3]

格隆汇12月4日丨中国太保(02601.HK)公告，公司近日收到国家金融监督管理总局("金融监管总局")《关 于王昱华中国太平洋保险(集团)股份有限公司董事任职资格的批覆》(金复[2025]687号)。金融监管总局 已核准了王昱华担任公司董事的任职资格。王昱华担任公司非执行董事的任期自2025年12月2日起生 效。 ...

中国太保（601601）(02601)公布，公司近日收到国家金融监督管理总局《关于王昱华中国太平洋保险 (集团)股份有限公司董事任职资格的批复》(金复[2025]687号)。金融监管总局已核准了王昱华女士担任 公司董事的任职资格。王昱华女士担任公司非执行董事的任期自2025年12月2日起生效。 ...

智通财经APP讯，中国太保(02601)公布，公司近日收到国家金融监督管理总局《关于王昱华中国太平洋 保险(集团)股份有限公司董事任职资格的批复》(金复[2025]687号)。金融监管总局已核准了王昱华女士 担任公司董事的任职资格。王昱华女士担任公司非执行董事的任期自2025年12月2日起生效。 ...

中 國 太 平 洋 保 險（集 團）股 份 有 限 公 司 董 事 會（「董事會」）成 員 載 列 如 下： | 執 | 行 董 | 事、董 | 事 | 長 | 獨立非執行董事 | | --- | --- | --- | --- | --- | --- | | 傅 | 帆 | | | | 陳 欣 | | | | | | | 林婷懿 | | 執 | 行 董 | 事、總 | 裁 | | 羅婉文 | | 趙永剛 | | | | | 金弘毅 | | | | | | | 姜旭平 | 非執行董事 黃迪南 王他竽 王昱華 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 董事名單與其角色和職能 路巧玲 John Robert DACEY 董事會目前已設立5個 委 員 會。下 表 提 供 各 董 事 會 成 員 在 這 些 委 員 會 中 所 擔 任 的 職 位。 – 1 – | | 委員會 | 審計與關聯 | 戰略與投資 | | | 科技創新與 | | --- | --- | --- ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 本 公 司 欣 然 宣 佈，本 公 司 近 日 收 到 國 家 金 融 監 督 管 理 總 局（「金融監管總 局」）《關 於 王 昱 華 中 國 太 平 洋 保 險（集 團）股 份 有 限 公 司 董 事 任 職 資 格 的 批 覆》（金 復[2025]687號）。金 融 監 管 總 局 已 核 准 了 王 昱 華 女 士 擔 任 本 公 司 董 事 的 任 職 資 格。王 昱 華 女 士 擔 任 本 公 司 非 執 行 董 事 的 任 期 自2025年12 月2日 起 生 效。 王 昱 華 女 士 的 履 歷，敬 請 參 見 該 通 函。 承董事會命 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601 ...

Group 1 - China Pacific Insurance has received approval from the financial regulatory authority for Wang Yuhua to serve as a director [1] - Shanghai Bank announced that the regulatory authority has approved Chen Lei's qualification as vice president [2] - Shanghai HuGong has decided to terminate the "Aerospace Equipment Manufacturing Base" fundraising project due to significant changes in project feasibility [3] Group 2 - Dongwang Times plans to reduce its stake by up to 1.20% through share sales [4] - Zhinancun intends to increase its capital by 100 million yuan in its wholly-owned subsidiary, Maigao Securities [5] - Jinxinnong reported a sales revenue of 115 million yuan from pig sales in November [6] Group 3 - Tiantan Biological has completed the Phase III clinical trial of its human prothrombin complex, showing good efficacy and safety for hemophilia B patients [7] - Beijete's subsidiary has signed a framework agreement for equity acquisition to gain control of Yunnan Wenye Nonferrous Metals [8] - Zhongsheng Pharmaceutical's RAY1225 injection has received approval for a new clinical trial indication for treating metabolic-associated fatty liver disease [9] Group 4 - Enhua Pharmaceutical's hydrochloride sulpiride tablets have passed the consistency evaluation for generic drugs [10] - Shenkong Co. plans to invest 60 million yuan in a semiconductor industry fund [11] - Lianhuan Pharmaceutical's subsidiary has received approval for its drug to pass the consistency evaluation for generic drugs [12] Group 5 - Dazhong Transportation has received approval to issue debt financing tools totaling 4.5 billion yuan [13] - Jintian Titanium Industry plans to invest 50 million yuan in an industry merger and acquisition fund [14] - Changchun Gas has committed over 1.7 billion yuan to gas facility upgrades [15] Group 6 - Laimei Pharmaceutical's innovative anti-cancer drug "Nano Carbon Iron" has received approval for clinical trials [16] - Longquan Co. has signed supply contracts worth approximately 50.76 million yuan for nuclear power components [17] - Igor plans to distribute a cash dividend of 1 yuan per 10 shares [18] Group 7 - Xingfa Group's subsidiary has signed a processing agreement for 80,000 tons of lithium iron phosphate [20] - Yunjigroup's director Wang Wanfeng has resigned for personal reasons [21] - Saiseng Pharmaceutical's application for the listing of a new drug has been accepted by the regulatory authority [22] Group 8 - Xinhua Medical has obtained registration certificates for two new medical devices [23] - Chaoying Electronics plans to invest 100 million USD in its Thai subsidiary for an AI circuit board expansion project [24] - Suzhou Planning's application to acquire 100% of Dongjin Aviation has been accepted by the Shenzhen Stock Exchange [25]